We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

5 hedge funds and large institutions have $291K invested in InspireMD, Inc. Series B Warrants in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more capital invested

Capital invested by funds: $74K → $291K (+$217K)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.08K
2
SM
Sabby Management
Florida
-$150
3
UBS Group
UBS Group
Switzerland
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
AFM
1
Anson Funds Management
Texas
$260K – – –
SM
2
Sabby Management
Florida
$30K -$150 -5,431 -0.3%
CH
3
CVI Holdings
Delaware
$1K +$1.33K +48,000 New
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
– -$2.08K -74,894 -80%
UBS Group
5
UBS Group
Switzerland
– -$6 -200 -3%

NSPRZ Hedge Fund Activity: Q1 2018 in Review

5 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q1 2018, worth a combined $291K — up 293% from $74K a quarter earlier.

Fund positioning in NSPRZ was balanced in Q1 2018: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 3 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $2.08K.

  • 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $291K of InspireMD, Inc. Series B Warrants stock for Q1 2018, up 293% quarter-over-quarter.
  • 1 fund opened new InspireMD, Inc. Series B Warrants positions in Q1 2018 and 1 closed out, a net change of 0 holders.
  • The largest InspireMD, Inc. Series B Warrants seller in Q1 2018 was Susquehanna International Group, an estimated $2.08K sold.

Based on aggregated 13F filings for Q1 2018.